MY133485A - Transdermal administration of reboxetine - Google Patents

Transdermal administration of reboxetine

Info

Publication number
MY133485A
MY133485A MYPI20006094A MYPI20006094A MY133485A MY 133485 A MY133485 A MY 133485A MY PI20006094 A MYPI20006094 A MY PI20006094A MY PI20006094 A MYPI20006094 A MY PI20006094A MY 133485 A MY133485 A MY 133485A
Authority
MY
Malaysia
Prior art keywords
disorders
disorder
reboxetine
transdermal administration
prodrugs
Prior art date
Application number
MYPI20006094A
Other languages
English (en)
Inventor
Ulla Hoeck
Bo Kreilgard
Helle Kristensen
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Publication of MY133485A publication Critical patent/MY133485A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MYPI20006094A 1999-12-23 2000-12-21 Transdermal administration of reboxetine MY133485A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9904750A SE9904750D0 (sv) 1999-12-23 1999-12-23 New formulation, use and method

Publications (1)

Publication Number Publication Date
MY133485A true MY133485A (en) 2007-11-30

Family

ID=20418276

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20006094A MY133485A (en) 1999-12-23 2000-12-21 Transdermal administration of reboxetine

Country Status (7)

Country Link
EP (1) EP1244431A1 (fr)
AR (1) AR026371A1 (fr)
AU (1) AU1068101A (fr)
MY (1) MY133485A (fr)
PE (1) PE20011024A1 (fr)
SE (1) SE9904750D0 (fr)
WO (1) WO2001047503A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1629843A3 (fr) * 1999-07-01 2006-03-15 Pharmacia & Upjohn Company LLC Reboxétine pour traiter le syndrome de fatigue chronique
DK1459750T3 (da) 1999-07-01 2005-08-15 Pharmacia & Upjohn Co Llc (S,S)-rebexetin til behandling af fibromyalgi og andre somatoforme lidelser
US20030082225A1 (en) * 2001-10-19 2003-05-01 Mason Paul Arthur Sterile, breathable patch for treating wound pain
EP2338873A1 (fr) 2009-12-22 2011-06-29 Gmeiner, Peter Nouveaux dérivés d'aminotétraline
TWI754702B (zh) 2016-12-28 2022-02-11 德商Ｕｃｂ製藥有限公司 （氮雜）吲哚－和苯並呋喃－３－磺醯胺類
DE102017127433A1 (de) 2017-11-21 2019-05-23 Lts Lohmann Therapie-Systeme Ag TTS auf Basis von klebenden Weichmacher-Polymer-Matrices
US20190381056A1 (en) 2018-06-17 2019-12-19 Axsome Therapeutics, Inc. Compositions for delivery of reboxetine
TW202016088A (zh) 2018-06-19 2020-05-01 德商Ｕｃｂ製藥有限公司 吡啶基及吡基-（氮）吲哚磺醯胺
EP3584244A1 (fr) 2018-06-20 2019-12-25 UCB Pharma GmbH Indolsulfonamides alkoxypyridinyl substitués
US20200147093A1 (en) 2018-10-15 2020-05-14 Axsome Therapeutics, Inc. Use of esreboxetine to treat nervous system disorders such as fibromyalgia
CN113993845A (zh) 2019-06-17 2022-01-28 优时比制药有限公司 作为治疗cns障碍例如多发性硬化的gpr17调节剂的n-(苯基)-吲哚-3-磺酰胺衍生物和相关化合物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5155198A (en) * 1997-08-28 1999-03-22 Robert Murdock Method and composition for transdermal administration of pharmacologic agent

Also Published As

Publication number Publication date
EP1244431A1 (fr) 2002-10-02
SE9904750D0 (sv) 1999-12-23
AU1068101A (en) 2001-07-09
AR026371A1 (es) 2003-02-05
PE20011024A1 (es) 2001-10-03
WO2001047503A1 (fr) 2001-07-05

Similar Documents

Publication Publication Date Title
MY133485A (en) Transdermal administration of reboxetine
EA200801488A1 (ru) Замещенные фенетиламины, обладающие серотонинергической и/или норэпинефринергической активностью
RS20120158A3 (en) Phenyl-piperazine Derivatives As Serotonin Resorption Inhibitors
GEP20125566B (en) Aryl-and heteroaryl-substituded tetrahydro-benzazepines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
HRP20080478T3 (en) 4-(2-phenylsulfanyl-phenyl)-piperidine derivatives as serotonin reuptake inhibitors
JP2008524262A5 (fr)
NO20010943L (no) Fremgangsmate for anvendelse og sammensetninger som innbefatter dopamin gjenopptakningsinhibitorer
MX2021006985A (es) Metodos para el tratamiento de la depresión.
MX2012014934A (es) Antagonistas de ciclohexilacetindinilo del receptor de la citocina quimioatrayente 2.
WO2011156248A3 (fr) Traitement thérapeutique d'un syndrome métabolique, du diabète de type 2, de l'obésité ou de prédiabètes
MX2007006082A (es) Tetrahidroisoquinolinas aril- y heteroaril-sustituidas, y uso de las mismas para bloquear la recaptacion de norepinefrina, dopamina y serotonina.
TW200744678A (en) Transdermal drug delivery devices containing O-desmethyl venlafaxing (ODV) or its salts
WO2002003975A3 (fr) Combinaisons d'inhibiteurs specifiques de recaptage de la serotonine et d'agents oestrogeniques
HRP20080262T3 (en) 4-(2-phenyloxyphenyl)-piperidine or -1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors
WO2007058998A3 (fr) Phenylpiperidines substituees a activite serotoninergique et proprietes therapeutiques ameliorees
JP2012526775A5 (fr)
BR0209342A (pt) Antidepressivos de azaheterociclilmetila derivados de 2,3 dihidro-1,4-dioxino[2,3-f]quinoxalina; método de tratamento usando tais compostos; processo para prepará-los
BR0209407A (pt) Antidepressivos de azaheterociclilmetila derivados de 7,8-dihidro-1,6,9-trioxa-3-aza-ciclopenta[a[]naftaleno , método de tratamento usando tais compostos e processo para prepará-los
WO2011156554A8 (fr) Antagonistes cyclohexyl-azétidinyliques de ccr2
DE60312874D1 (de) Kombinationstherapie mit verwendung eines serotonin-wiederaufnahmehemmers
IL198396A0 (en) Methods for treating disruptive behavior disorders
NO20090971L (no) 1H-quinolin-4-on forbindelser med affinitet for GABA-receptoren, fremgangsmater, anvendelser og sammensetninger
NO20065809L (no) Fremstilling av nye substituerte haloaren-forbindelser
TW200507853A (en) Use of s-10-hydroxy-10,11-dihydro-carbamazepine for the treatment of anxiety and bipolar disorders
NO20005621L (no) Nye medikamentkombinasjoner